136 related articles for article (PubMed ID: 12876669)
1. Natural killer receptors in patients with lymphoproliferative diseases of granular lymphocytes.
Zambello R; Semenzato G
Semin Hematol; 2003 Jul; 40(3):201-12. PubMed ID: 12876669
[TBL] [Abstract][Full Text] [Related]
2. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function.
Cambiaggi A; Orengo AM; Meazza R; Sforzini S; Tazzari PL; Lauria F; Raspadori D; Zambello R; Semenzato G; Moretta L; Ferrini S
Blood; 1996 Mar; 87(6):2369-75. PubMed ID: 8630400
[TBL] [Abstract][Full Text] [Related]
3. T-cell type lymphoproliferative disease of granular lymphocytes (LDGL) is equipped with a phenotypic pattern typical of effector cytotoxic cells.
Baesso I; Pavan L; Boscaro E; Miorin M; Facco M; Trentin L; Agostini C; Zambello R; Semenzato G
Leuk Res; 2007 Mar; 31(3):371-7. PubMed ID: 16982092
[TBL] [Abstract][Full Text] [Related]
4. Characteristic expansion of CD45RA CD27 CD28 CCR7 lymphocytes with stable natural killer (NK) receptor expression in NK- and T-cell type lymphoproliferative disease of granular lymphocytes.
Mitsui T; Maekawa I; Yamane A; Ishikawa T; Koiso H; Yokohama A; Handa H; Matsushima T; Tsukamoto N; Murakami H; Nojima Y; Karasawa M
Br J Haematol; 2004 Jul; 126(1):55-62. PubMed ID: 15198732
[TBL] [Abstract][Full Text] [Related]
5. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis.
Semenzato G; Zambello R; Starkebaum G; Oshimi K; Loughran TP
Blood; 1997 Jan; 89(1):256-60. PubMed ID: 8978299
[TBL] [Abstract][Full Text] [Related]
6. The immunophenotypic attributes of NK cells and NK-cell lineage lymphoproliferative disorders.
Morice WG
Am J Clin Pathol; 2007 Jun; 127(6):881-6. PubMed ID: 17509985
[TBL] [Abstract][Full Text] [Related]
7. Role of tumor necrosis factor-alpha and its specific 55-Kd and 75-Kd receptors in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Trentin L; Bulian P; Cassatella M; Raimondi R; Chisesi T; Agostini C; Semenzato G
Blood; 1992 Oct; 80(8):2030-7. PubMed ID: 1327287
[TBL] [Abstract][Full Text] [Related]
8. IL-12 is involved in the activation of CD3+ granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Trentin L; Cassatella MA; Raimondi R; Cerutti A; Enthammer C; Facco M; Agostini C; Semenzato G
Br J Haematol; 1996 Feb; 92(2):308-14. PubMed ID: 8602990
[TBL] [Abstract][Full Text] [Related]
9. Genotypic evaluation of killer immunoglobulin-like receptors in NK-type lymphoproliferative disease of granular lymphocytes.
Scquizzato E; Teramo A; Miorin M; Facco M; Piazza F; Noventa F; Trentin L; Agostini C; Zambello R; Semenzato G
Leukemia; 2007 May; 21(5):1060-9. PubMed ID: 17361229
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes.
Zambello R; Trentin L; Ciccone E; Bulian P; Agostini C; Moretta A; Moretta L; Semenzato G
Blood; 1993 May; 81(9):2381-5. PubMed ID: 8481518
[TBL] [Abstract][Full Text] [Related]
11. The raft marker GM1 identifies functional subsets of granular lymphocytes in patients with CD3+ lymphoproliferative disease of granular lymphocytes.
Zambello R; Cabrelle A; Trentin L; Agostini C; Semenzato G; Viola A
Leukemia; 2004 Apr; 18(4):771-6. PubMed ID: 15044927
[TBL] [Abstract][Full Text] [Related]
12. Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative natural killer-type lymphoproliferative disease of granular lymphocytes.
Zambello R; Loughran TP; Trentin L; Pontisso P; Battistella L; Raimondi R; Facco M; Sancetta R; Agostini C; Pizzolo G
Leukemia; 1995 Jul; 9(7):1207-11. PubMed ID: 7630196
[TBL] [Abstract][Full Text] [Related]
13. DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3-CD56+ fractions.
Choi YL; Makishima H; Ohashi J; Yamashita Y; Ohki R; Koinuma K; Ota J; Isobe Y; Ishida F; Oshimi K; Mano H
Leukemia; 2004 Mar; 18(3):556-65. PubMed ID: 14737071
[TBL] [Abstract][Full Text] [Related]
14. Development of lymphoproliferative disorder of granular lymphocytes in association with hairy cell leukemia.
Xie XY; Sorbara L; Kreitman RJ; Fukushima PI; Kingma DW; Stetler-Stevenson M
Leuk Lymphoma; 2000 Mar; 37(1-2):97-104. PubMed ID: 10721773
[TBL] [Abstract][Full Text] [Related]
15. Release of natural killer cytotoxic factor in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Trentin L; Agostini C; Chisesi T; Vespignani M; Pizzolo G; Pandolfi F; Ensoli F; Semenzato G
Leuk Res; 1989; 13(4):315-22. PubMed ID: 2497276
[TBL] [Abstract][Full Text] [Related]
16. ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL).
Epling-Burnette PK; Bai F; Wei S; Chaurasia P; Painter JS; Olashaw N; Hamilton A; Sebti S; Djeu JY; Loughran TP
Oncogene; 2004 Dec; 23(57):9220-9. PubMed ID: 15516985
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions.
Pascal V; Schleinitz N; Brunet C; Ravet S; Bonnet E; Lafarge X; Touinssi M; Reviron D; Viallard JF; Moreau JF; Déchanet-Merville J; Blanco P; Harlé JR; Sampol J; Vivier E; Dignat-George F; Paul P
Eur J Immunol; 2004 Oct; 34(10):2930-40. PubMed ID: 15368309
[TBL] [Abstract][Full Text] [Related]
18. [NK- and T-cell granular lymphocyte-proliferative disorders].
Sakata T; Amano M; Yamada K; Oshimi K; Kobayashi Y; Togawa A
Rinsho Ketsueki; 1990 Apr; 31(4):462-7. PubMed ID: 2381062
[TBL] [Abstract][Full Text] [Related]
19. Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells.
Gattazzo C; Teramo A; Passeri F; De March E; Carraro S; Trimarco V; Frezzato F; Berno T; Barilà G; Martini V; Piazza F; Trentin L; Facco M; Semenzato G; Zambello R
Haematologica; 2014 Dec; 99(12):1826-33. PubMed ID: 25193965
[TBL] [Abstract][Full Text] [Related]
20. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
